Critical Contrast: Ultralife (ULBI) and Integer (NYSE:ITGR)

Ultralife (NASDAQ: ULBI) and Integer (NYSE:ITGR) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

Insider and Institutional Ownership

How to Become a New Pot Stock Millionaire

27.4% of Ultralife shares are owned by institutional investors. Comparatively, 95.9% of Integer shares are owned by institutional investors. 38.1% of Ultralife shares are owned by company insiders. Comparatively, 4.8% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Ultralife and Integer’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ultralife 8.94% 7.74% 6.24%
Integer 4.56% 11.13% 3.17%

Valuation and Earnings

This table compares Ultralife and Integer’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ultralife $85.53 million 1.82 $7.64 million N/A N/A
Integer $1.46 billion 1.25 $66.67 million $2.81 20.43

Integer has higher revenue and earnings than Ultralife.

Risk & Volatility

Ultralife has a beta of -0.57, indicating that its stock price is 157% less volatile than the S&P 500. Comparatively, Integer has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Ultralife and Integer, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ultralife 0 0 0 0 N/A
Integer 0 3 1 0 2.25

Integer has a consensus price target of $51.00, indicating a potential downside of 11.15%. Given Integer’s higher possible upside, analysts plainly believe Integer is more favorable than Ultralife.

Summary

Integer beats Ultralife on 7 of the 12 factors compared between the two stocks.

Ultralife Company Profile

Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. The segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, and ENTELLION brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and Internet retailers. Ultralife Corporation was founded in 1990 and is headquartered in Newark, New York.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products. It also provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems. In addition, the company provides products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products. Further, it offers cardiac and neuromodulation products, such as batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads, and enclosures; pacemakers, implantable cardiac defibrillators, cardiac resynchronization therapy devices, implantable cardiac monitors, and other implantable devices; and neuromodulation medical devices. Additionally, it offers customized battery power and management systems, charging and docking stations, and power supplies for energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Frisco, Texas.

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply